UBS Group’s PharmaCyte Biotech PMCB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.6K | Buy |
|
|||||
|
2025
Q1 | $14.9K | Buy |
|
|||||
|
2024
Q4 | $2.94K | Sell |
|
|||||
|
2024
Q3 | $16K | Sell |
|
|||||
|
2024
Q2 | $54K | Buy |
|
|||||
|
2024
Q1 | $21 | Sell |
|
|||||
|
2023
Q4 | $29 | Buy |
|
|||||
|
2023
Q3 | $19 | Hold |
|
|||||
|
2023
Q2 | $25 | Sell |
|
|||||
|
2023
Q1 | $4.91K | Buy |
|
|||||
|
2022
Q4 | $27 | Hold |
|
|||||
|
2022
Q3 | $0 | Hold |
|
|||||
|
2022
Q2 | $0 | Sell |
|
|||||
|
2022
Q1 | $13K | Buy |
|
|||||
|
2021
Q4 | $9K | Buy |
|
|||||
|
2021
Q3 | $11K | Buy |
|